Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 21 of 99

  1. BP45248

    Hoffmann-La Roche

    Not applicable

    phase 1 other active

    1 trial

  2. BP45325

    Hoffmann-La Roche

    Healthy males volunteers

    phase 1 other active

    1 trial

  3. BP45361

    Hoffmann-La Roche

    Parkinson’s Disease

    phase 1 other active

    1 trial

  4. BP45378

    Hoffmann-La Roche

    Huntington’s Disease Gene Expansion Carriers

    phase 1 other active

    1 trial

  5. BP45669

    Hoffmann-La Roche

    Not Applicable (N/A)

    phase 1 other active

    1 trial

  6. BP45670

    Hoffmann-La Roche

    Type 2 Diabetes and obesity

    phase 1 other active

    1 trial

  7. BP45800

    Hoffmann-La Roche

    Obesity or Overweight

    phase 1 other active

    1 trial

  8. BP45801

    Hoffmann-La Roche

    Healthy volunteers

    phase 1 other active

    1 trial

  9. BP45910

    Hoffmann-La Roche

    Healthy Overweight or Obese

    phase 1 other active

    1 trial

  10. BP45932

    Hoffmann-La Roche

    Not Applicable

    phase 1 other active

    1 trial

  11. BP45980

    Hoffmann-La Roche

    Type 2 Diabetes Mellitus (T2DM) and overweight or obesity

    phase 1 other active

    1 trial

  12. BP46028

    Hoffmann-La Roche

    Not Applicable

    phase 1 other active

    1 trial

  13. BP46037

    Hoffmann-La Roche

    Not Applicable

    phase 1 other active

    1 trial

  14. BP46355

    Hoffmann-La Roche

    Stable Coronary Artery Disease (CAD)

    phase 1 other active

    1 trial

  15. BP46585

    Hoffmann-La Roche

    Not Applicable

    phase 1 other active

    1 trial

  16. BPT567

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule terminated

    1 trial

  17. BPX-601

    Regeneron UK Limited

    Prostate Cancer

    phase 1 gene therapy active

    1 trial

  18. BPX-601

    Regeneron UK Limited

    Metastatic Castration-resistant Prostate Cancer

    phase 1 mab terminated

    1 trial

  19. BRI-1501

    Yung NA

    Gastric Ulcer

    phase 1 small molecule completed

    1 trial

  20. BRIVA-10-24

    Lacuna Pharma Pty Ltd

    Epilepsy

    phase 1 other active

    1 trial

  21. BS-02

    Blue Earth Diagnostics Ireland Ltd

    Treatment of human papilloma virus (HPV) associated infections, precancers and cancers

    phase 1 other active

    1 trial

  22. BS-03

    Blue Earth Diagnostics Ireland Ltd

    Treatment of human papilloma virus (HPV) associated infections and cancers

    phase 1 other active

    1 trial

  23. BUPRO-05-25

    Lacuna Pharma Pty Ltd

    Seasonal affective disorder, Major depressive disorder

    phase 1 other active

    1 trial

  24. BUPRO-06-25

    Lacuna Pharma Pty Ltd

    Seasonal affective disorder, Major depressive disorder

    phase 1 other active

    1 trial

  25. BUPRO-07-24

    Lacuna Pharma Pty Ltd

    major depressive illness

    phase 1 other active

    1 trial

  26. BUPRO-08-24

    Lacuna Pharma Pty Ltd

    major depressive illness

    phase 1 other active

    1 trial

  27. BUSPAR® 30 mg Tablet

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  28. BXCL501 80 Micrograms

    BioXcel Therapeutics

    Schizophrenia

    phase 1 small molecule active

    1 trial

  29. BZ019

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Large B-cell Lymphoma

    phase 1 mab active

    1 trial

  30. Baroreceptor Stimulation

    Rhythm Pharmaceuticals Netherlands B.V.

    Hypertension

    phase 1 other completed

    1 trial

  31. Beclomethasone dipropionate BAI

    Teva Pharma GmbH

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  32. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    phase 1 other completed

    1 trial

  33. Behavior Therapy-RISE

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 1 other completed

    1 trial

  34. Bemarituzumab

    Prime Medicine

    Gastrointestinal Cancer

    phase 1 mab completed

    1 trial

  35. Bemnifosbuvir (BEM)

    Atea Pharmaceuticals

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  36. Bemnifosbuvir (BEM)

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    2 trials

  37. Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fasting conditions

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  38. Bemnifosbuvir (BEM)/Ruzasvir (RZR) as a fixed-dose combination

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule active

    1 trial

  39. Bempegaldesleukin

    Nektar Therapeutics UK Limited

    Covid-19

    phase 1 small molecule completed

    1 trial

  40. Bempegaldesleukin (NKTR-214)

    Nektar Therapeutics UK Limited

    Metastatic Melanoma

    phase 1 mab terminated

    1 trial

  41. Benazepril HCl 40 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  42. Benralizumab

    AstraZeneca

    Healthy Subjects

    phase 1 mab completed

    1 trial

  43. Bepranemab

    Lacuna Pharma Pty Ltd

    Progressive Supranuclear Palsy

    phase 1 small molecule active

    1 trial

  44. Bexarotene (Targretin®)

    LIGAND PHARMACEUTICALS INC

    Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)

    phase 1 small molecule completed

    1 trial

  45. Bicalutamide

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  46. Bilateral Cerebellar deep brain stimulation

    Shandong Suncadia Medicine Co.,

    Stroke

    phase 1 other active

    1 trial

  47. Bimatoprost Ophthalmic Solution, 0.01%

    Amneal Pharma Europe Ltd

    Open-angle Glaucoma

    phase 1 small molecule active

    1 trial

  48. Binimetinib

    Takeda

    ALK Gene Rearrangement

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.